HEADER HYDROLASE 22-JUL-05 2BX4 TITLE CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 3241-3546; COMPND 5 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 6 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 7 EC: 3.4.22.69; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS SIN2774; SOURCE 3 ORGANISM_TAXID: 235410; SOURCE 4 GENE: 1A; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TUNER (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HYDROLASE, ANTI-PARALLEL B-BARREL, ANTI-PARALLEL A- HELICES, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.H.G.VERSCHUEREN,J.R.MESTERS,J.BIGALKE,R.HILGENFELD REVDAT 7 31-JAN-24 2BX4 1 REMARK REVDAT 6 07-DEC-22 2BX4 1 COMPND SOURCE DBREF REVDAT 5 24-JUL-19 2BX4 1 REMARK REVDAT 4 13-JUL-11 2BX4 1 VERSN REVDAT 3 24-FEB-09 2BX4 1 VERSN REVDAT 2 02-NOV-05 2BX4 1 AUTHOR JRNL REVDAT 1 26-SEP-05 2BX4 0 JRNL AUTH J.TAN,K.H.G.VERSCHUEREN,K.ANAND,J.SHEN,M.YANG,Y.XU,Z.RAO, JRNL AUTH 2 J.BIGALKE,B.HEISEN,J.R.MESTERS,K.CHEN,X.SHEN,H.JIANG, JRNL AUTH 3 R.HILGENFELD JRNL TITL PH-DEPENDENT CONFORMATIONAL FLEXIBILITY OF THE SARS-COV MAIN JRNL TITL 2 PROTEINASE (M(PRO)) DIMER: MOLECULAR DYNAMICS SIMULATIONS JRNL TITL 3 AND MULTIPLE X-RAY STRUCTURE ANALYSES. JRNL REF J.MOL.BIOL. V. 354 25 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16242152 JRNL DOI 10.1016/J.JMB.2005.09.012 REMARK 2 REMARK 2 RESOLUTION. 2.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 108.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 5910 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 14.000 REMARK 3 FREE R VALUE TEST SET COUNT : 964 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.86 REMARK 3 REFLECTION IN BIN (WORKING SET) : 368 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.51 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 76.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.18000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -1.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.563 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.435 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 44.175 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.873 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2368 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3218 ; 1.360 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 297 ; 4.093 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;33.379 ;24.299 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 385 ;15.352 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;12.557 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 364 ; 0.025 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1803 ; 0.000 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 985 ; 0.123 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1586 ; 0.289 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 127 ; 0.148 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 62 ; 0.086 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.174 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1534 ; 0.143 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2391 ; 0.248 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 962 ; 0.247 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 827 ; 0.391 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 8 REMARK 3 ORIGIN FOR THE GROUP (A): 1.2366 5.5530 18.1928 REMARK 3 T TENSOR REMARK 3 T11: 0.0099 T22: 0.1303 REMARK 3 T33: 0.0111 T12: 0.1200 REMARK 3 T13: -0.1176 T23: -0.2848 REMARK 3 L TENSOR REMARK 3 L11: 32.7831 L22: 2.1454 REMARK 3 L33: 53.0145 L12: 7.3754 REMARK 3 L13: -13.2933 L23: -7.8023 REMARK 3 S TENSOR REMARK 3 S11: -0.1407 S12: -2.0291 S13: 2.4547 REMARK 3 S21: 0.5856 S22: -0.0967 S23: 0.3838 REMARK 3 S31: -1.4549 S32: -1.3295 S33: 0.2373 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 9 A 98 REMARK 3 ORIGIN FOR THE GROUP (A): 15.8558 -15.6365 0.3632 REMARK 3 T TENSOR REMARK 3 T11: 0.2262 T22: 0.0690 REMARK 3 T33: -0.0029 T12: 0.1802 REMARK 3 T13: -0.0688 T23: -0.1241 REMARK 3 L TENSOR REMARK 3 L11: 8.8952 L22: 6.8243 REMARK 3 L33: 4.9829 L12: -6.2869 REMARK 3 L13: 0.9085 L23: 0.2114 REMARK 3 S TENSOR REMARK 3 S11: 0.8683 S12: 1.0205 S13: -0.8183 REMARK 3 S21: -0.9141 S22: -0.5676 S23: 0.0746 REMARK 3 S31: 1.2580 S32: 0.4094 S33: -0.3007 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 99 A 188 REMARK 3 ORIGIN FOR THE GROUP (A): 13.5832 -5.2689 13.2369 REMARK 3 T TENSOR REMARK 3 T11: -0.2806 T22: -0.2899 REMARK 3 T33: -0.2193 T12: 0.0579 REMARK 3 T13: -0.0075 T23: -0.0715 REMARK 3 L TENSOR REMARK 3 L11: 9.2237 L22: 5.1728 REMARK 3 L33: 7.7828 L12: -4.2698 REMARK 3 L13: 3.2031 L23: 1.4174 REMARK 3 S TENSOR REMARK 3 S11: -0.2700 S12: -0.3868 S13: -0.0081 REMARK 3 S21: 0.3453 S22: 0.3447 S23: -0.3801 REMARK 3 S31: 0.2310 S32: 0.1788 S33: -0.0747 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 189 A 200 REMARK 3 ORIGIN FOR THE GROUP (A): 19.6233 -9.9461 26.7271 REMARK 3 T TENSOR REMARK 3 T11: 0.5642 T22: 0.5161 REMARK 3 T33: 0.0913 T12: 0.5865 REMARK 3 T13: -0.1740 T23: -0.1575 REMARK 3 L TENSOR REMARK 3 L11: 0.4789 L22: 47.7220 REMARK 3 L33: 3.4136 L12: -1.0461 REMARK 3 L13: -1.1779 L23: 7.4184 REMARK 3 S TENSOR REMARK 3 S11: 0.3920 S12: 0.0580 S13: 0.2644 REMARK 3 S21: 0.7964 S22: -1.2769 S23: 0.0735 REMARK 3 S31: 1.7350 S32: 0.9308 S33: 0.8849 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 201 A 269 REMARK 3 ORIGIN FOR THE GROUP (A): 13.2156 14.5159 32.8522 REMARK 3 T TENSOR REMARK 3 T11: 0.1793 T22: -0.0330 REMARK 3 T33: 0.1083 T12: 0.0458 REMARK 3 T13: -0.1927 T23: -0.2104 REMARK 3 L TENSOR REMARK 3 L11: 10.3234 L22: 7.9684 REMARK 3 L33: 9.2496 L12: -3.3574 REMARK 3 L13: 1.6726 L23: -1.8080 REMARK 3 S TENSOR REMARK 3 S11: -0.3722 S12: -0.3823 S13: 0.6395 REMARK 3 S21: 0.7307 S22: -0.3224 S23: 0.1034 REMARK 3 S31: -0.9619 S32: 0.0057 S33: 0.6946 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 270 A 300 REMARK 3 ORIGIN FOR THE GROUP (A): 5.6919 8.4480 30.5950 REMARK 3 T TENSOR REMARK 3 T11: 0.0223 T22: 0.1360 REMARK 3 T33: 0.4869 T12: 0.0263 REMARK 3 T13: -0.0756 T23: -0.4005 REMARK 3 L TENSOR REMARK 3 L11: 10.8504 L22: 8.8297 REMARK 3 L33: 21.6063 L12: -2.7056 REMARK 3 L13: 1.0953 L23: -1.2449 REMARK 3 S TENSOR REMARK 3 S11: -0.0740 S12: -0.4675 S13: -0.5388 REMARK 3 S21: 0.1345 S22: -0.6887 S23: 1.5703 REMARK 3 S31: 0.5265 S32: -1.7591 S33: 0.7628 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2BX4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1290025017. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8125 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6890 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.790 REMARK 200 RESOLUTION RANGE LOW (A) : 108.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1UJ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 54.11500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.27850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 54.11500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 22.27850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2002 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -131.45 54.18 REMARK 500 ASP A 34 46.51 -100.59 REMARK 500 THR A 45 58.74 -115.51 REMARK 500 ALA A 46 -53.42 55.53 REMARK 500 ASN A 51 88.04 -162.03 REMARK 500 ALA A 70 64.84 -102.20 REMARK 500 LEU A 75 -157.32 -93.66 REMARK 500 ASN A 84 -102.41 57.86 REMARK 500 HIS A 134 8.08 82.66 REMARK 500 LYS A 137 46.58 -96.18 REMARK 500 SER A 139 -57.60 51.81 REMARK 500 TYR A 154 -89.63 59.33 REMARK 500 PRO A 168 -5.04 -52.90 REMARK 500 GLN A 189 85.26 -68.57 REMARK 500 ALA A 191 89.33 -68.90 REMARK 500 ARG A 217 -10.93 -140.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2005 DISTANCE = 9.58 ANGSTROMS REMARK 525 HOH A2007 DISTANCE = 6.67 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O5S RELATED DB: PDB REMARK 900 STRUCTURE MODEL OF THE CATALYTIC DOMAIN OF SARS- REMARK 900 CORONAVIRUSPOLYMERASE REMARK 900 RELATED ID: 1P4X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS PROTEIN FROM STAPHYLOCOCCUS AUREUS REMARK 900 RELATED ID: 1P76 RELATED DB: PDB REMARK 900 3D STRUCTURE OF THE SUBSTRATE-BOUND SARS CHYMOTRYPSIN-LIKECYSTEINE REMARK 900 PROTEINASE REMARK 900 RELATED ID: 1P9S RELATED DB: PDB REMARK 900 CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE : BASIS FORDESIGN OF REMARK 900 ANTI-SARS DRUGS REMARK 900 RELATED ID: 1P9T RELATED DB: PDB REMARK 900 CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE : BASIS FORDESIGN OF REMARK 900 ANTI-SARS DRUGS REMARK 900 RELATED ID: 1P9U RELATED DB: PDB REMARK 900 CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE : BASIS FORDESIGN OF REMARK 900 ANTI-SARS DRUGS REMARK 900 RELATED ID: 1PA5 RELATED DB: PDB REMARK 900 STRUCTURE OF SARS CORONAVIRUS PROTEINASE REMARK 900 RELATED ID: 1PUK RELATED DB: PDB REMARK 900 3C-LIKE PROTEINASE DOMAIN STRUCTURE OF HUMAN CORONAVIRUS(STRAIN REMARK 900 SARS) MODELED IN-SILICO REMARK 900 RELATED ID: 1Q1X RELATED DB: PDB REMARK 900 CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE : BASIS FORDESIGN OF REMARK 900 ANTI-SARS LIGANDS REMARK 900 RELATED ID: 1Q2W RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAINPROTEASE REMARK 900 RELATED ID: 1Q4Z RELATED DB: PDB REMARK 900 S1 SUBUNIT MODEL OF SARS CORONAVIRUS S PROTEIN REMARK 900 RELATED ID: 1QZ8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS NSP9 REMARK 900 RELATED ID: 1SSK RELATED DB: PDB REMARK 900 STRUCTURE OF THE N-TERMINAL RNA-BINDING DOMAIN OF THE SARSCOV REMARK 900 NUCLEOCAPSID PROTEIN REMARK 900 RELATED ID: 1SXF RELATED DB: PDB REMARK 900 HOMOLOGY MODEL FOR HUMAN SARS-CORONAVIRUS RNA-DEPENDENT REMARK 900 RNAPOLYMERASE REMARK 900 RELATED ID: 1UJ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO) REMARK 900 RELATED ID: 1UK2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO) AT REMARK 900 PH8.0 REMARK 900 RELATED ID: 1UK3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO) AT REMARK 900 PH7.6 REMARK 900 RELATED ID: 1UK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO) REMARK 900 COMPLEXED WITH AN INHIBITOR REMARK 900 RELATED ID: 1UW7 RELATED DB: PDB REMARK 900 NSP9 REPLICASE PROTEIN FROM SARS-CORONAVIRUS. REMARK 900 RELATED ID: 1WNC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SARS-COV SPIKE PROTEIN FUSION CORE REMARK 900 RELATED ID: 1XAK RELATED DB: PDB REMARK 900 STRUCTURE OF THE SARS-CORONAVIRUS ORF7A ACCESSORY PROTEIN REMARK 900 RELATED ID: 1XJP RELATED DB: PDB REMARK 900 MOLECULAR DOCKING MODEL OF SARS CORONAVIRUS SPIKE PROTEINS1 SUBUNIT REMARK 900 WITH ITS RECEPTOR, ACE2 REMARK 900 RELATED ID: 1XJR RELATED DB: PDB REMARK 900 THE STRUCTURE OF A RIGOROUSLY CONSERVED RNA ELEMENT WITHINTHE SARS REMARK 900 VIRUS GENOME REMARK 900 RELATED ID: 2BW6 RELATED DB: PDB REMARK 900 THE STRUCTURE OF SARS 3C LIKE PROTEASE AT 1.9A REMARK 900 RELATED ID: 2BX3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212) DBREF 2BX4 A 1 306 UNP P0C6U8 R1A_SARS 3241 3546 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 A 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN FORMUL 2 HOH *46(H2 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 CYS A 44 5 4 HELIX 3 3 GLU A 47 ASN A 51 5 5 HELIX 4 4 ASN A 53 ARG A 60 1 8 HELIX 5 5 SER A 62 PHE A 66 5 5 HELIX 6 6 ILE A 200 GLY A 215 1 16 HELIX 7 7 THR A 226 TYR A 237 1 12 HELIX 8 8 THR A 243 GLY A 258 1 16 HELIX 9 9 ALA A 260 ASN A 274 1 15 HELIX 10 10 THR A 292 GLN A 299 1 8 SHEET 1 AA 7 VAL A 73 GLN A 74 0 SHEET 2 AA 7 LEU A 67 ALA A 70 -1 O ALA A 70 N VAL A 73 SHEET 3 AA 7 MET A 17 CYS A 22 -1 O GLN A 19 N GLN A 69 SHEET 4 AA 7 THR A 25 LEU A 32 -1 O THR A 25 N CYS A 22 SHEET 5 AA 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA 7 LEU A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90 SHEET 1 AB 5 LYS A 100 PHE A 103 0 SHEET 2 AB 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 102 SHEET 3 AB 5 VAL A 148 ASP A 153 -1 O GLY A 149 N CYS A 160 SHEET 4 AB 5 THR A 111 TYR A 118 -1 O SER A 113 N PHE A 150 SHEET 5 AB 5 SER A 121 ALA A 129 -1 O SER A 121 N TYR A 118 SHEET 1 AC 3 LYS A 100 PHE A 103 0 SHEET 2 AC 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 102 SHEET 3 AC 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 CRYST1 108.230 44.557 54.198 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009240 0.000000 0.000000 0.00000 SCALE2 0.000000 0.022443 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018451 0.00000